v3.26.1
Acquisitions and Merger Agreement (Details Narrative)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 25, 2026
USD ($)
Vote
$ / shares
shares
Jan. 06, 2026
USD ($)
shares
Dec. 31, 2025
USD ($)
$ / shares
Jan. 31, 2026
USD ($)
Dec. 31, 2025
USD ($)
$ / shares
Oct. 31, 2025
USD ($)
shares
Jan. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Oct. 31, 2023
USD ($)
Jun. 30, 2026
USD ($)
$ / shares
Jun. 30, 2025
USD ($)
Mar. 31, 2025
USD ($)
Jun. 30, 2026
USD ($)
$ / shares
Jun. 30, 2025
USD ($)
Dec. 31, 2025
USD ($)
$ / shares
Dec. 31, 2024
USD ($)
Jan. 22, 2026
USD ($)
Oct. 01, 2025
USD ($)
Business Combination [Line Items]                                    
Goodwill     $ 5,177,000   $ 5,177,000         $ 6,466,000     $ 6,466,000   $ 5,177,000     $ 1,600,000
Ownership percentage       60.00%   100.00%     51.00%                  
Accounts recievable     1,078,000   1,078,000         3,042,000     3,042,000   1,078,000      
Accounts recievable from non controlling interest     58,747,000   58,747,000         10,097,000     10,097,000   58,747,000      
Carrying value of investment     $ 0   $ 0         $ 24,855,000     $ 24,855,000   $ 0      
Common stock, par value | $ / shares     $ 0.01   $ 0.01         $ 0.01     $ 0.01   $ 0.01      
Revenues                   $ 5,123,000 $ 1,198,000   $ 9,303,000 $ 2,300,000        
Net Income (Loss)                   (33,993,000) (75,157,000) $ (8,462,000) (41,114,000) (83,619,000)        
Notes payable                   59,769,000     59,769,000          
Goodwill impairment                             $ 0 $ 0    
Amortization expense                   42,000,000 0   75,000,000 $ 0        
Common Stock                                    
Business Combination [Line Items]                                    
Net Income (Loss)                   0 $ 0 $ 0            
East Coast Nuclear Pharmacy Acquisition                                    
Business Combination [Line Items]                                    
Goodwill           $ 1,574,000                        
Percentage of voting interests in the investee           100.00%                        
Effective date of acquisition           Oct. 31, 2025                        
Cash consideration           $ 2,500,000                        
Acquisition cash consideration           2,000,000                        
Notes payable     $ 500,000   $ 500,000 500,000       $ 0     0   $ 500,000      
Numed Diagnostics, LLC Acquisition                                    
Business Combination [Line Items]                                    
Goodwill       $ 1,239,000                         $ 1,300,000  
Percentage of issued and outstanding shares       4.00%                            
Option to purchase       $ 500,000                            
Percentage of voting interests in the investee       60.00%                            
Effective date of acquisition       Jan. 31, 2026                            
Cash consideration       $ 800,000                            
Acquisition cash consideration       $ 813,000                            
Business combination, additional voting equity interest acquired, percentage       36.00%                            
Business combination, consideration transferred, equity interest       $ 50,000                            
Consideration       $ 358,000                 $ 400,000          
Renergen Acquisition                                    
Business Combination [Line Items]                                    
Effective date of acquisition   Jan. 06, 2026                                
Acquisition cash consideration   $ 5,000                                
Business combination, consideration transferred, equity interest   $ 92,897,000                                
Common stock exchange ratio   0.09196                                
Renergen Acquisition | Common Stock                                    
Business Combination [Line Items]                                    
Issuance of consideration shares | shares   14,270,000                                
Merger Agreement | Renergen Acquisition | ASPI Term Loan Facility                                    
Business Combination [Line Items]                                    
Maximum borrowing capacity $ 200,000,000                                  
PET Labs Acquisition                                    
Business Combination [Line Items]                                    
Purchase consideration                 $ 2,000,000                  
Advance payment                 $ 500,000                  
Payble amount         $ 500,000   $ 700,000 $ 300,000                    
Percentage of issued and outstanding shares                         49.00%          
Option to purchase                         $ 2,200,000          
Ownership percentage                 51.00%                  
Aquisition Paid Amount     $ 0                              
One 30 Seven Inc. [Member]                                    
Business Combination [Line Items]                                    
Acquisition cash consideration           150,000,000                        
Asset acquisition, initial cash payment           150,000,000                        
Additional payments upon completion of certain milestones           $ 17,000,000                        
Royalty percentage           6.00%                        
Product license duration           15 years                        
Asset acquisition, cost           $ 2,700,000                        
Fair value of equity consideration issued           2,600,000                        
Direct costs of acquisition           $ 7,000,000                        
Asset acquisition date           Oct. 31, 2025                        
One 30 Seven Inc. [Member] | Creber Mini Unit [Member]                                    
Business Combination [Line Items]                                    
Estimated cost of acquisition           $ 4,500,000                        
Acquisition period           18 months                        
One 30 Seven Inc. [Member] | Midi And Maxi [Member]                                    
Business Combination [Line Items]                                    
Acquisition period           18 months                        
One 30 Seven Inc. [Member] | Common Stock                                    
Business Combination [Line Items]                                    
Asset acquisition shares issuable | shares           266,113                        
One 30 Seven Inc. [Member] | Minimum [Member] | Midi And Maxi [Member]                                    
Business Combination [Line Items]                                    
Estimated cost of acquisition           $ 12,500,000                        
One 30 Seven Inc. [Member] | Maximum [Member] | Midi And Maxi [Member]                                    
Business Combination [Line Items]                                    
Estimated cost of acquisition           $ 13,000,000                        
ENDRA Life Sciences, Inc. | Merger Agreement                                    
Business Combination [Line Items]                                    
Number of vote per share | Vote 10                                  
Minimum cash balance requirement at closing $ 3,800,000                                  
Noble | Renergen Acquisition | Class B Units                                    
Business Combination [Line Items]                                    
Share of units received in exchange for contributed equity interest | shares 55,500,000                                  
Noble | Merger Agreement                                    
Business Combination [Line Items]                                    
Gross proceedsfrom investment $ 50,000,000                                  
Noble | Merger Agreement | Pre-Funded Warrants                                    
Business Combination [Line Items]                                    
Exercise price per share | $ / shares $ 0.0001                                  
Sale of stock price per unit less exercise price | $ / shares $ 6.57                                  
Noble | Merger Agreement | Class A Units                                    
Business Combination [Line Items]                                    
Number of units agrred to sell | shares 4,594,218                                  
Sale of stock, price per unit | $ / shares $ 6.57                                  
Noble | Merger Agreement | Class B Units                                    
Business Combination [Line Items]                                    
Number of units agrred to sell | shares 3,054,185                                  
Sale of stock, price per unit | $ / shares $ 6.57